Lotus Eye Hospital and Institute Limited share price

NSE: LOTUSEYE · ISIN INE947I01017

Key numbers

Market cap
₹ 239 Cr
Current price
₹ 115.07
52-week high / low
₹ 147 / 98
Stock P/E
1,438.4
Book value
₹ 28.2
Dividend yield
0.00%
ROCE
1.0%
ROE
0.1%
Debt to equity
0.26
Sales growth (3 yrs)
4.5%
Profit growth (3 yrs)
-73.0%
1-year return
-4.7%

About Lotus Eye Hospital and Institute Limited

Lotus Eye Hospital and Institute Limited, a specialty eye care hospital, provides eye care and related services in India. The company offers ReLEx SMILE, a refractive lenticule extraction small incision lenticule extraction; touch-free laser; lasik eye surgery; Epi-LASIK, an epithelial laser in situ keratomileusis; Intralase, a blade-free technique to create the corneal flap; Zyoptix Supracor laser technology; robotic femto laser cataract surgery; phacoemulsification; paediatric eye care and squint surgery; and micro incision cataract surgery treatments. It provides treatment services for various eye problems, such as refractive errors, cataract, glaucoma, retinal disease/diabetic eye care, neuro ophthalmology, binocular vision, and corneal infections, as well as various eye-related courses. The company was formerly known as Lotus Eye Care Hospital Limited and changed its name to Lotus Eye Hospital and Institute Limited in April 2013. Lotus Eye Hospital and Institute Limited was founded in 1989 and is based in Coimbatore, India.

Quarterly results

Consolidated figures in ₹ crores

Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales1413141417
Operating profit11103
Net profit10-0-01
EPS (₹)0.260.06-0.13-0.150.30

Peers in Medical Care Facilities

Data for information only, not investment advice. Prices end of day.